CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma

Published:2022-03 Issue: Volume:24 Page:755-771
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Cai Juan,Chen Zhiqiang,Zhang Yao,Wang Jinguo,Zhang Zhengrong^ORCID,Wu Jindao,Mao Jiading,Zuo Xueliang^ORCID

Funder

National Natural Science Foundation of China

Anhui Provincial Natural Science Foundation

Jiangsu Province Natural Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference54 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Advances in immunotherapy for hepatocellular carcinoma;Sangro;Nat. Rev. Gastroenterol. Hepatol.,2021

3. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Primers,2021

4. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

5. Connections between metabolism and epigenetics in cancers;Thakur;Semin. Cancer Biol.,2019

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression;International Immunopharmacology;2024-10

2. Exploring the impact of circRNAs on cancer glycolysis: Insights into tumor progression and therapeutic strategies;Non-coding RNA Research;2024-09

3. Research status and potential applications of circRNAs affecting colorectal cancer by regulating ferroptosis;Life Sciences;2024-09

4. Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects;Journal of Experimental & Clinical Cancer Research;2024-08-03

5. The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets;Clinical and Translational Medicine;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3